GENETIC CONTROL OF VULVAL CELL FATES IN C ELEGANS
线虫外阴细胞命运的遗传控制
基本信息
- 批准号:2634684
- 负责人:
- 金额:$ 27.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-01 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegans antibody biological signal transduction cell cycle proteins cell differentiation cell growth regulation developmental genetics gene expression gene mutation genetic regulation laboratory rabbit laboratory rat mitogen activated protein kinase phosphorylation polymerase chain reaction transcription factor
项目摘要
The long-term objective of the proposed research is to understand how cell
signalling leads to the induction of specific cell fates during
development. A well-studied example of cell signalling is the induction
of the hermaphrodite vulva during development in C. elegans. Genetic and
molecular analyses have shown that the response to this inductive signal
is mediated by a receptor tyrosine kinase/Ras signal transduction pathway
that has been remarkably well conserved during metazoan evolution. While
the chain of events leading to the activation of the last signal
transduction protein (MAP kinase) has been well described, little is known
about the events that occur after MAP kinase activation. Thus, a
fundamentally important and yet poorly understood step is how the last
signal transduction molecule(s) in this cell signaling pathway regulates
the activity of transcription factors in the nucleus, ultimately resulting
in cellular differentiation. Furthermore, it is not clear how activation
of the same signal transduction pathway at multiple times during
development can elicit markedly different cellular responses in different
cell types.
The proposed research is directed at defining the molecular mechanisms
that link activation of this signal transduction cascade with specific
changes in gene expression that result in the execution of specific cell
fates. One goal is to define the role of two C. elegans MAP kinase
homologs that have recently been shown to function in vulval induction.
Another goal is to determine how MAP kinases regulate the activity of LIN-
31, a transcription factor that controls vulval gene expression. A third
goal is to determine how LIN-31 regulates the choice of induced versus
uninduced cell fates during vulval induction, and whether LIN-31 plays a
role in defining the cell-type specificity of the transcriptional response
to activation of the signal transduction cascade. A final goal is to
genetically identify additional genes that act downstream of MAP kinases,
in order to define additional links between activation of MAP kinases and
induction of vulval cell fates.
Because the receptor tyrosine kinase/Ras signal transduction pathway is so
highly conserved, and because constitutive activation of this signaling
pathway is known to be oncogenic in mammals, the proposed studies will be
directly relevant to cell signalling processes in humans, both during
normal development and in tumorigenesis.
这项研究的长期目标是了解细胞是如何
信号传导导致诱导特定的细胞命运,
发展 细胞信号传导的一个充分研究的例子是诱导
雌雄同体外阴的发育过程中C.优雅的 遗传和
分子分析表明,对这种感应信号的反应
由受体酪氨酸激酶/Ras信号转导途径介导
在后生动物进化过程中被保存得非常好。 而
导致最后一个信号激活的事件链
转导蛋白(MAP激酶)已被充分描述,但知之甚少
关于MAP激酶激活后发生的事件。因此
最重要但又知之甚少的一步是,
该细胞信号通路中的信号转导分子调节
细胞核中转录因子的活性,最终导致
在细胞分化中。 此外,目前还不清楚如何激活
同一信号转导通路的不同时间点,
发育可以在不同的细胞中引起明显不同的细胞反应。
细胞类型。
拟议的研究旨在确定分子机制
将信号传导级联的激活与特定的
基因表达的变化导致特定细胞的执行,
命运 一个目标是定义两个C的作用。线虫MAP激酶
同源物,最近已被证明在外阴诱导中起作用。
另一个目标是确定MAP激酶如何调节LIN-1的活性。
31,控制外阴基因表达的转录因子。 第三
目的是确定LIN-31如何调节诱导与
在外阴诱导过程中未诱导的细胞命运,以及LIN-31是否起作用。
在定义转录反应的细胞类型特异性中的作用
信号传导级联的激活。 最终目标是
从遗传学上鉴定作用于MAP激酶下游的其它基因,
为了确定MAP激酶的激活与
外阴细胞命运的诱导。
由于受体酪氨酸激酶/Ras信号转导途径是如此的复杂,
高度保守,并且因为这种信号传导的组成性激活
已知通路在哺乳动物中是致癌的,因此拟议的研究将在
与人类的细胞信号传导过程直接相关,
正常发育和肿瘤发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STUART K KIM其他文献
STUART K KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STUART K KIM', 18)}}的其他基金
High-throughput technology for automated single cell expression analysis for C. e
用于大肠杆菌自动单细胞表达分析的高通量技术
- 批准号:
7830334 - 财政年份:2009
- 资助金额:
$ 27.7万 - 项目类别:
High-throughput technology for automated single cell expression analysis for C. e
用于大肠杆菌自动单细胞表达分析的高通量技术
- 批准号:
7937888 - 财政年份:2009
- 资助金额:
$ 27.7万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 27.7万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 27.7万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 27.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)